Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · IEX Real-Time Price · USD
2.870
-0.060 (-2.05%)
At close: Jul 19, 2024, 4:00 PM
2.950
+0.080 (2.79%)
Pre-market: Jul 22, 2024, 7:35 AM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $172.43 million as of July 22, 2024. Its market cap has decreased by -16.78% in one year.
Market Cap
172.43M
Enterprise Value
-49.73M
1-Year Change
-16.78%
Ranking
Category
Stock Price
$2.87
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $172.43M, a decrease of -72.12%. That is a compound annual growth rate of -34.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 172.40M | -22.48% |
| Dec 29, 2023 | 222.40M | 0.63% |
| Dec 30, 2022 | 221.00M | -19.23% |
| Dec 31, 2021 | 273.60M | -55.76% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metagenomi | 178.33M |
| Puma Biotechnology | 176.55M |
| Fennec Pharmaceuticals | 174.59M |
| Innate Pharma | 174.04M |
| MediWound | 172.67M |
| OrganiGram Holdings | 170.56M |
| Rigel Pharmaceuticals | 169.61M |
| Adverum Biotechnologies | 169.58M |